Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$384M |
| 2 |
Mondelez International
MDLZ
|
+$125M |
| 3 |
NVIDIA
NVDA
|
+$116M |
| 4 |
Johnson & Johnson
JNJ
|
+$105M |
| 5 |
Church & Dwight Co
CHD
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$276M |
| 2 |
Apple
AAPL
|
+$180M |
| 3 |
Duke Energy
DUK
|
+$75.7M |
| 4 |
ConocoPhillips
COP
|
+$73.6M |
| 5 |
Broadcom
AVGO
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 9.83% |
| 3 | Utilities | 6.25% |
| 4 | Real Estate | 4.8% |
| 5 | Consumer Discretionary | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Amgen
AMGN
$240B
| $898K | 0.01% |
+2,786
| New | +$911K |
|
1002
Enova International
ENVA
$6.17B
| $893K | 0.01% |
10,652
-43,921
| -80% | -$3.4M |
|
1003
Contango Silver & Gold Inc
CTGO
$675M
| $889K | 0.01% |
+46,158
| New | +$945K |
|
|
ZUO
1004
DELISTED
Zuora, Inc.
ZUO
| $888K | 0.01% |
+103,033
| New | +$914K |
|
1005
PagSeguro Digital
PAGS
$2.4B
| $885K | 0.01% |
102,769
-233,554
| -69% | -$2.7M |
|
1006
Mercury Insurance
MCY
$5.89B
| $884K | 0.01% |
14,036
+10,093
| +256% | +$600K |
|
1007
RxSight
RXST
$260M
| $884K | 0.01% |
+17,883
| New | +$916K |
|
1008
Hackett Group
HCKT
$276M
| $880K | 0.01% |
33,512
+8,115
| +32% | +$204K |
|
1009
Ovintiv
OVV
$18.2B
| $876K | 0.01% |
22,860
-288,873
| -93% | -$12.5M |
|
1010
Nomad Foods
NOMD
$1.69B
| $875K | 0.01% |
45,905
-41,425
| -47% | -$762K |
|
1011
First Commonwealth Financial
FCF
$2.12B
| $855K | 0.01% |
+49,828
| New | +$817K |
|
1012
AtriCure
ATRC
$2.51B
| $853K | 0.01% |
30,418
-36,603
| -55% | -$902K |
|
1013
MoonLake Immunotherapeutics
MLTX
$1.31B
| $850K | 0.01% |
+16,855
| New | +$790K |
|
1014
Calix
CALX
$2.51B
| $849K | 0.01% |
+21,891
| New | +$804K |
|
|
RDUS
1015
DELISTED
Radius Recycling
RDUS
| $849K | 0.01% |
+45,783
| New | +$731K |
|
|
DCBO
1016
Docebo
DCBO
$610M
| $846K | 0.01% |
19,148
+5,648
| +42% | +$231K |
|
|
EB
1017
DELISTED
Eventbrite
EB
| $846K | 0.01% |
309,910
-60,631
| -16% | -$231K |
|
1018
CoStar Group
CSGP
$13.3B
| $843K | 0.01% |
11,169
-96,252
| -90% | -$7.3M |
|
1019
American Public Education
APEI
$846M
| $842K | 0.01% |
+57,097
| New | +$934K |
|
1020
Pilgrim's Pride
PPC
$7.57B
| $841K | 0.01% |
18,273
-536,789
| -97% | -$22.7M |
|
1021
WesBanco
WSBC
$3.91B
| $839K | 0.01% |
28,157
-45,236
| -62% | -$1.39M |
|
1022
Energy Recovery
ERII
$398M
| $835K | 0.01% |
48,008
-59,669
| -55% | -$941K |
|
1023
Olema Pharmaceuticals
OLMA
$913M
| $834K | 0.01% |
+69,841
| New | +$893K |
|
1024
OFG Bancorp
OFG
$2.21B
| $825K | 0.01% |
18,356
+12,428
| +210% | +$535K |
|
|
GOLD
1025
Gold.com Inc
GOLD
$1.33B
| $823K | 0.01% |
+18,627
| New | +$712K |
|
Similar funds
Michael Gelband's Q3 2024 Portfolio in Review
As of Q3 2024, Michael Gelband held 2,213 positions worth $16.4B, up 12% from $14.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Michael Gelband deployed $963M of net new capital in Q3 2024, opening 752 new positions and adding to 404 existing holdings. Its largest new stake was Mondelez International: 1,784,906 shares worth $131M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 10% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was ConocoPhillips, an estimated $73.6M trimmed.
- Michael Gelband's largest Q3 2024 buy was Mondelez International: 1,784,906 shares worth $131M.
- Michael Gelband added most to Microsoft in Q3 2024, an estimated $384M increase.
- Michael Gelband's biggest Q3 2024 reduction was ConocoPhillips, cutting an estimated $73.6M.
- Michael Gelband fully exited Amazon in Q3 2024, selling an estimated $276M.
- Michael Gelband's ten largest holdings make up 37% of its $16.4B portfolio in Q3 2024.
- Michael Gelband opened 752 new positions and closed 645 in Q3 2024.
- Michael Gelband's portfolio value rose 12% quarter-over-quarter to $16.4B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.